191 related articles for article (PubMed ID: 18601732)
1. Procalcitonin in liver transplantation: are high levels due to donors or recipients?
Eyraud D; Ben Ayed S; Tanguy ML; Vézinet C; Siksik JM; Bernard M; Fratéa S; Movschin M; Vaillant JC; Coriat P; Hannoun L
Crit Care; 2008; 12(4):R85. PubMed ID: 18601732
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation.
Wagner FD; Jonitz B; Potapov EV; Qedra N; Wegscheider K; Abraham K; Ivanitskaia EA; Loebe M; Hetzer R
Circulation; 2001 Sep; 104(12 Suppl 1):I192-6. PubMed ID: 11568054
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin in the setting of complicated postoperative course after liver transplantation.
Perrakis A; Yedibela S; Schellerer V; Hohenberger W; Müller V
Transplant Proc; 2010 Dec; 42(10):4187-90. PubMed ID: 21168660
[TBL] [Abstract][Full Text] [Related]
4. Perioperative changes of procalcitonin levels in patients undergoing liver transplantation.
Kaido T; Ogawa K; Fujimoto Y; Mori A; Hatano E; Okajima H; Uemoto S
Transpl Infect Dis; 2014 Oct; 16(5):790-6. PubMed ID: 25154523
[TBL] [Abstract][Full Text] [Related]
5. High levels of procalcitonin in the early phase after pediatric liver transplantation indicate poor postoperative outcome.
Zant R; Melter M; Schlitt HJ; Loss M; Ameres M; Knoppke B; Kunkel J
Hepatogastroenterology; 2014; 61(133):1344-9. PubMed ID: 25436308
[TBL] [Abstract][Full Text] [Related]
6. Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications.
Prieto B; Llorente E; González-Pinto I; Alvarez FV
Clin Chem Lab Med; 2008; 46(5):660-6. PubMed ID: 18839468
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit.
van den Broek MA; Olde Damink SW; Winkens B; Broelsch CE; Malagó M; Paul A; Saner FH
Liver Transpl; 2010 Mar; 16(3):402-10. PubMed ID: 20209599
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin in early allograft dysfunction after orthotopic liver transplantation: a retrospective single centre study.
Frick K; Beller EA; Kalisvaart M; Dutkowski P; Schüpbach RA; Klinzing S
BMC Gastroenterol; 2022 Aug; 22(1):404. PubMed ID: 36045337
[TBL] [Abstract][Full Text] [Related]
9. Post-operative kinetics of procalcitonin after lung transplantation.
Desmard M; Benbara A; Boudinet S; Mal H; Dehoux M; Thabut G; Montravers P
J Heart Lung Transplant; 2015 Feb; 34(2):189-94. PubMed ID: 25447581
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin-a new diagnostic tool in complications following liver transplantation.
Kuse ER; Langefeld I; Jaeger K; Külpmann WR
Intensive Care Med; 2000 Mar; 26 Suppl 2():S187-92. PubMed ID: 18470718
[TBL] [Abstract][Full Text] [Related]
11. Analysis of systemic and regional procalcitonin serum levels during liver transplantation.
Fazakas J; Gondos T; Varga M; Sarvary E; Horovitz P; Perner F
Transpl Int; 2003 Jul; 16(7):465-70. PubMed ID: 12728303
[TBL] [Abstract][Full Text] [Related]
12. Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin.
Zazula R; Prucha M; Tyll T; Kieslichova E
Crit Care; 2007; 11(6):R131. PubMed ID: 18088403
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin for infections in the first week after pediatric liver transplantation.
Cousin VL; Lambert K; Trabelsi S; Galetto-Lacour A; Posfay-Barbe KM; Wildhaber BE; McLin VA
BMC Infect Dis; 2017 Feb; 17(1):149. PubMed ID: 28201980
[TBL] [Abstract][Full Text] [Related]
14. Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation.
Potapov EV; Wagner FD; Loebe M; Ivanitskaia EA; Müller C; Sodian R; Jonitz B; Hetzer R
Int J Cardiol; 2003 Dec; 92(2-3):163-7. PubMed ID: 14659848
[TBL] [Abstract][Full Text] [Related]
15. [Kinetics, diagnostic and prognostic value of procalcitonin after cardiac surgery].
Kallel S; Abid M; Jarraya A; Abdenadher M; Mnif E; Frikha I; Ayadi F; Karoui A
Ann Biol Clin (Paris); 2012 Oct; 70(5):567-80. PubMed ID: 23047903
[TBL] [Abstract][Full Text] [Related]
16. [Peripheral Th17 cell frequencies predict postoperative complications in patients with hepatitis B virus-related liver cirrhosis following liver transplantation].
Wang Y; Li X; Cao J; Gao Q; Dou J; Nan Y
Zhonghua Gan Zang Bing Za Zhi; 2015 Aug; 23(8):616-21. PubMed ID: 26447627
[TBL] [Abstract][Full Text] [Related]
17. The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy.
Venkateswaran RV; Dronavalli V; Lambert PA; Steeds RP; Wilson IC; Thompson RD; Mascaro JG; Bonser RS
Transplantation; 2009 Aug; 88(4):582-8. PubMed ID: 19696643
[TBL] [Abstract][Full Text] [Related]
18. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations.
Aouifi A; Piriou V; Blanc P; Bouvier H; Bastien O; Chiari P; Rousson R; Evans R; Lehot JJ
Br J Anaesth; 1999 Oct; 83(4):602-7. PubMed ID: 10673877
[TBL] [Abstract][Full Text] [Related]
19. Kinetic of procalcitonin in the early postoperative course following heart transplantation.
Madershahian N; Wittwer T; Strauch J; Wippermann J; Rahmanian P; Franke UF; Wahlers T
J Card Surg; 2008; 23(5):468-73. PubMed ID: 18928484
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?
Eberhard OK; Langefeld I; Kuse ER; Brunkhorst FM; Kliem V; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
Clin Transplant; 1998 Jun; 12(3):206-11. PubMed ID: 9642511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
